Protein detail
MAP4
Microtubule-associated protein 4 (MAP-4)
Protein symbol MAP4 | UniProt ID | EVMP score 0.75 |
Frequency 21 | Transmembrane count | Protein classification FDA approved drug targetsPlasma proteinsPredicted intracellular proteins |
Basic Information
Protein Names
Microtubule-associated protein 4 (MAP-4)
Protein Class
FDA approved drug targetsPlasma proteinsPredicted intracellular proteins
Protein Function
- FDA approved drug targets:Small molecule drugs
- Predicted intracellular proteins
Ensembl
Entrez Gene Symbol
Gene Description
Microtubule associated protein 4
Chromosome
3
Position
47850690-48089272
Frequency
21
EVMP Score
0.75
Fluorescence & Localization
Function & Pathway
Protein Function
- FDA approved drug targets:Small molecule drugs
- Predicted intracellular proteins
Cellular Component
Molecular Function
Biological Process
Mediation Categories
Clinical-translation mediation
Relations & Evidence
Enzyme-Mediated Modification
33 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| MAP4 | MARK1 | Q9P0L2 | S | 663 | phosphorylation | KEA | KEA:8631898 |
| MAP4 | CHEK1 | O14757 | T | 925 | phosphorylation | phosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPProtMapperPhosphoSitePhosphoSite_ProtMapper | |
| MAP4 | MAPK14 | Q16539 | S | 696 | phosphorylation | PhosphoSite | |
| MAP4 | MAPK14 | Q16539 | S | 787 | phosphorylation | PhosphoSite | |
| MAP4 | MAPK14 | Q16539 | S | 280 | phosphorylation | KEA | KEA:17570479 |
| MAP4 | MAPK14 | Q16539 | T | 521 | phosphorylation | KEA | KEA:17570479 |
| MAP4 | TTK | P33981 | S | 928 | phosphorylation | PhosphoSite | |
| MAP4 | TTK | P33981 | T | 927 | phosphorylation | PhosphoSite | |
| MAP4 | MARK3 | P27448 | S | 941 | phosphorylation | MIMPHPRD_MIMPphosphoELM_MIMPPhosphoSite_MIMP | |
| MAP4 | MARK3 | P27448 | S | 1,073 | phosphorylation | MIMPHPRD_MIMPphosphoELM_MIMPPhosphoSite_MIMP |
Ligand-Receptor Signaling
5 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| intracellular | intracellular | LOCATE | No | No | No | No | No |
| intracellular | intracellular | ComPPI | No | No | No | No | No |
| intracellular | intracellular | GO_Intercell | No | No | No | No | No |
| intracellular | intracellular | UniProt_location | No | No | No | No | No |
| intracellular | intracellular | OmniPath | No | No | No | No | No |
Regulatory Interaction Network
5 records.
Protein Complex Composition
14 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| IL13RA1MAP4K3 | P78552Q8IVH8 | 0:0 | hu.MAP2 | |||
| MAP3K11MAP4K2TRAF2 | Q12851Q12933Q16584 | 1:1:1 | CompleatCFinder | Compleat:HC8575 | ||
| EIF2AMAP4K3 | Q8IVH8Q9BY44 | 0:0 | hu.MAP | |||
| MAP4K1 | Q92918 | 2 | PDB | PDB:7siuPDB:9n9xPDB:7m0kPDB:9nc2PDB:8pasPDB:8fkoPDB:7r9pPDB:9cztPDB:9nacPDB:9nbsPDB:6cqePDB:7m0mPDB:7m0lPDB:7l26PDB:9bi8PDB:6nfzPDB:9czxPDB:8pauPDB:8cdwPDB:8fjzPDB:8xn7PDB:9n7rPDB:9bj1PDB:6nfyPDB:9czuPDB:6ng0PDB:8fh4PDB:9d00PDB:6cqdPDB:7r9nPDB:9bikPDB:9czwPDB:7l24PDB:7l25PDB:7r9tPDB:7kac |
Page 2 of 2Previous
Isolation & Detection Technology
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential UltracentrifugationSize Exclusion Chromatography | Mass spectrometry | 1 | 27894104 |
Sequence, Structure & Domains
Sequences
Length
1,152
Mass
121,005
Sequence
MADLSLADALTEPSPDIEGEIKRDFIATLEAEAFDDVVGETVGKTDYIPLLDVDEKTGNSESKKKPCSETSQIEDTPSSKPTLLANGGHGVEGSDTTGSPTEFLEEKMAYQEYPNSQNWPEDTNFCFQPEQVVDPIQTDPFKMYHDDDLADLVFPSSATADTSIFAGQNDPLKDSYGMSPCNTAVVPQGWSVEALNSPHSESFVSPEAVAEPPQPTAVPLELAKEIEMASEERPPAQALEIMMGLKTTDMAPSKETEMALAKDMALATKTEVALAKDMESPTKLDVTLAKDMQPSMESDMALVKDMELPTEKEVALVKDVRWPTETDVSSAKNVVLPTETEVAPAKDVTLLKETERASPIKMDLAPSKDMGPPKENKKETERASPIKMDLAPSKDMGPPKENKIVPAKDLVLLSEIEVAQANDIISSTEISSAEKVALSSETEVALARDMTLPPETNVILTKDKALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVKEVGLLKDMSPLSETEMALGKDVTPPPETEVVLIKNVCLPPEMEVALTEDQVPALKTEAPLAKDGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQKGISEDSHLESLQDVGQSAAPTFMISPETVTGTGKKCSLPAEEDSVLEKLGERKPCNSQPSELSSETSGIARPEEGRPVVSGTGNDITTPPNKELPPSPEKKTKPLATTQPAKTSTSKAKTQPTSLPKQPAPTTIGGLNKKPMSLASGLVPAAPPKRPAVASARPSILPSKDVKPKPIADAKAPEKRASPSKPASAPASRSGSKSTQTVAKTTTAAAVASTGPSSRSPSTLLPKKPTAIKTEGKPAEVKKMTAKSVPADLSRPKSTSTSSMKKTTTLSGTAPAAGVVPSRVKATPMPSRPSTTPFIDKKPTSAKPSSTTPRLSRLATNTSAPDLKNVRSKVGSTENIKHQPGGGRAKVEKKTEAAATTRKPESNAVTKTAGPIASAQKQPAGKVQIVSKKVSYSHIQSKCGSKDNIKHVPGGGNVQIQNKKVDISKVSSKCGSKANIKHKPGGGDVKIESQKLNFKEKAQAKVGSLDNVGHLPAGGAVKTEGGGSEAPLCPGPPAGEEPAISEAAPEAGAPTSASGLNGHPTLSGGGDQREAQTLDSQIQETSI
Alternative Products
Event=Alternative splicing; Named isoforms=7; Comment=Additional isoforms seem to exist.; Name=1; IsoId=P27816-1; Sequence=Displayed; Name=2; IsoId=P27816-2; Sequence=VSP_003200; Name=3; IsoId=P27816-3; Sequence=VSP_032065, VSP_032068, VSP_032072, VSP_032073, VSP_032074, VSP_032075; Name=4; IsoId=P27816-4; Sequence=VSP_032066, VSP_032067, VSP_032069, VSP_032070, VSP_032076; Name=5; IsoId=P27816-5; Sequence=VSP_032071, VSP_032077, VSP_032079; Name=6; IsoId=P27816-6; Sequence=VSP_032078; Name=7; IsoId=P27816-7; Sequence=VSP_043240, VSP_043241
Alternative Sequence
1..151; Missing (in isoform 3); 1..82; Missing (in isoform 4); 83..221; LLANGGHGVEGSDTTGSPTEFLEEKMAYQEYPNSQNWPEDTNFCFQPEQVVDPIQTDPFKMYHDDDLADLVFPSSATADTSIFAGQNDPLKDSYGMSPCNTAVVPQGWSVEALNSPHSESFVSPEAVAEPPQPTAVPLE -> METTGDQGIEGMAYMDENRNITFTCPRTPSELINKSSPLEVLGSAACEKLPTPTPQVVKEGDSFPDT (in isoform 4); 98..99; GS -> EA (in isoform 7); 100..1152; Missing (in isoform 7); 152..437; LVFPSSATADTSIFAGQNDPLKDSYGMSPCNTAVVPQGWSVEALNSPHSESFVSPEAVAEPPQPTAVPLELAKEIEMASEERPPAQALEIMMGLKTTDMAPSKETEMALAKDMALATKTEVALAKDMESPTKLDVTLAKDMQPSMESDMALVKDMELPTEKEVALVKDVRWPTETDVSSAKNVVLPTETEVAPAKDVTLLKETERASPIKMDLAPSKDMGPPKENKKETERASPIKMDLAPSKDMGPPKENKIVPAKDLVLLSEIEVAQANDIISSTEISSAEKVA -> MSLSDKQTASLTAAYGQLSKGKPAECRMDSPKEISQAGFEWQRTEGKLNEIGLNVSMDGQPKDGLVKNASFLEQNKLCFFEGKLDKELSIEMQDKDCQEASGHLESRYVISETCHPLEGNSVHQKTSEFHLGLIEGPDKNKTIPVQGKVAGKNGLETKSQSDLDFPGAADIPTRYVKEQETSVWNPSFHPVAQGSLGSREATPGEMENSITPGCPVIGVVNDNSEQLKCESPLLVSLAHPAPIIEHSPTTIPPITMVFTQEHLNASCHIRDHDKELEK (in isoform 3); 225..271; EIEMASEERPPAQALEIMMGLKTTDMAPSKETEMALAKDMALATKTE -> NGQEIAPAQISKSLMVDNYTKDGVPGQERPKGPSAVVPSTSTGG (in isoform 4); 275..666; AKDMESPTKLDVTLAKDMQPSMESDMALVKDMELPTEKEVALVKDVRWPTETDVSSAKNVVLPTETEVAPAKDVTLLKETERASPIKMDLAPSKDMGPPKENKKETERASPIKMDLAPSKDMGPPKENKIVPAKDLVLLSEIEVAQANDIISSTEISSAEKVALSSETEVALARDMTLPPETNVILTKDKALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVKEVGLLKDMSPLSETEMALGKDVTPPPETEVVLIKNVCLPPEMEVALTEDQVPALKTEAPLAKDGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQKGISEDSHLESLQDVGQSAAPTFMISPETVTGTGKKCSLPAEEDSVLEKLGERKPCNSQPSELSSETS -> PITTAIETVNIHGDHSLKNKAELADSMKNEAGIDEGHVIGESESVHSGASKHSVEKVTELAKGHLLPGVPVEDQSLPGEARALEGYADRGNFPAHPVNEEKETKEGSVAVQIPDLLEDKAQKLSFCEDQNAQDRNSKGSDSLNKKVDLTLLSPKSENDKLKEISLACKITELESVSLPTPEIQSDFLHSKVEAPPSEVADTLVIMTASKGVRLPEPKDKILETPQKMTEKSESKTPGEGKKEDKSRMAEPMKGYMRPTKSRGLTPLLPKSTIQEQERHKQLKSA (in isoform 4); 322..666; WPTETDVSSAKNVVLPTETEVAPAKDVTLLKETERASPIKMDLAPSKDMGPPKENKKETERASPIKMDLAPSKDMGPPKENKIVPAKDLVLLSEIEVAQANDIISSTEISSAEKVALSSETEVALARDMTLPPETNVILTKDKALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVKEVGLLKDMSPLSETEMALGKDVTPPPETEVVLIKNVCLPPEMEVALTEDQVPALKTEAPLAKDGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQKGISEDSHLESLQDVGQSAAPTFMISPETVTGTGKKCSLPAEEDSVLEKLGERKPCNSQPSELSSETS -> LPEPKDKILETPQKMTEKSESKTPGEGKKEDKSRMAEPMKGYMRPTKSRGLTPLLPKSTIQEQERHKQLKSA (in isoform 5); 441..631; ETEVALARDMTLPPETNVILTKDKALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVKEVGLLKDMSPLSETEMALGKDVTPPPETEVVLIKNVCLPPEMEVALTEDQVPALKTEAPLAKDGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQKGISEDSHLESLQDVGQSAAPTFMISPETVTGT -> TEEAVLNQAPQQKKAVRRALSECSHLSVPPAVNLADKYPELPAREEPSSGLLPPPSSPMPSPTPGKLGAPAMKRSMTVGEEQTASYKLSPGKLPILSTKEIPPFICEEPVAKKREELAHFSNSSSNSGKKELGTAGLYLHSKLEQIPEGSSKEKGQEDFSETRIDSCSQVCQRGEKQPGQTALA (in isoform 3); 558..730; Missing (in isoform 2); 635..666; CSLPAEEDSVLEKLGERKPCNSQPSELSSETS -> EIEVTATQSTPSFLFEKPPRD (in isoform 3); 703..716; PLATTQPAKTSTSK -> VGARMVVIFYCHNF (in isoform 3); 717..1152; Missing (in isoform 3); 939..953; Missing (in isoform 4); 954..1022; Missing (in isoform 5); 1088..1152; TEGGGSEAPLCPGPPAGEEPAISEAAPEAGAPTSASGLNGHPTLSGGGDQREAQTLDSQIQETSI -> IETYRLTFRANARARTDHGADIVSRPPHFPGGPNSGSRVLGPLSRAVH (in isoform 6); 1151..1152; SI -> N (in isoform 5)
3D Structural Models
Domain & Motif Annotations
Compositional Bias
53..67; Basic and acidic residues; 68..81; Polar residues; 371..384; Basic and acidic residues; 644..653; Basic and acidic residues; 654..666; Polar residues; 680..689; Polar residues; 704..725; Polar residues; 769..786; Basic and acidic residues; 788..819; Low complexity; 839..848; Basic and acidic residues; 861..878; Low complexity; 911..929; Polar residues; 1105..1119; Low complexity; 1142..1152; Polar residues
Repeat
248..261; 1; 262..275; 2; 276..289; 3; 290..303; 4; 304..317; 5; 318..331; 6; 332..345; 7; 346..351; 8; truncated; 352..377; 26 residues 1; 378..403; 26 residues 2; 408..421; 9; 422..433; 10; 434..447; 11; 448..461; 12; 462..475; 13; 476..489; 14; 490..503; 15; 504..517; 16; 532..545; 17; 923..953; Tau/MAP 1; 992..1022; Tau/MAP 2; 1023..1053; Tau/MAP 3; 1054..1085; Tau/MAP 4
Region
50..100; Disordered; 248..545; 17 X 14 AA tandem repeats; 362..401; Disordered; 641..991; Disordered; 1074..1152; Disordered
Clinical Relevance
Disease Involvement
FDA approved drug targets
Drug Targets
FDA approved drug targetsPatented-recorded targetLiterature-reported targetClinical trial targetSuccessful target
Interaction Protein
ENSG00000014216ENSG00000044574
Interaction Count
2
Interaction Dataset
intact_biogrid_opencellbiogrid_opencell